PHARMACEUTICAL INDUSTRY NEWS
Yahoo! News: Business - Pharmaceutical
Business - Pharmaceutical
- CVS gets restraining order in drug abuse probe
(Reuters)
Reuters - A federal judge on Tuesday granted CVS Caremark Corp a temporary restraining order allowing it to keep selling controlled prescription drugs at two Florida pharmacies at the center of raids by the U.S. Drug Enforcement Agency.
- Skepticism grows around Medco/Express Scripts deal
(Reuters)
Reuters - Objections to Express Scripts' $29 billion plan to buy rival pharmacy benefits manager Medco Health Solutions are accumulating as U.S. antitrust regulators weigh whether they have enough evidence to stop the megamerger.
- FDA question's Amgen drug for prostate cancer
(AP)
AP - Scientists for the Food and Drug Administration say an Amgen drug slowed the spread of cancer to the bone in men with hard-to-treat prostate cancer, though the drug failed to extend life and carried significant side effects.
- Mom charged in NY death fights jail call recording
(AP)
AP - A pharmaceuticals multimillionaire charged with murdering her autistic 8-year-old son at a hotel has lost a bid to stop jail officials from recording her phone calls and turning them over to prosecutors.
- DEA suspends Cardinal Health license in Florida
(Reuters)
Reuters - Cardinal Health Inc said on Friday that the U.S. Drug Enforcement Administration has suspended its license to distribute potentially addictive medicines from a facility in Lakeland, Florida, citing concern over unusually high shipments to four pharmacies.
- Walgreen sales hit by exit from Express Scripts
(Reuters)
Reuters - Walgreen Co is being hit by its withdrawal from the Express Scripts Inc pharmacy network and by a much-weaker-than-expected flu season, leading it to temper its expectations for the number of prescriptions it will fill this year.
- Summary Box: AstraZeneca to cut 7,300 jobs
(AP)
AP - JOB CUTS: Drugmaker AstraZeneca PLC said it will cut another 7,300 jobs as it warned Thursday of a tough year ahead, due to government spending cuts on health care and stiff competition.
- AstraZeneca to cut 7,300 jobs as outlook darkens
(AP)
AP - Drug maker AstraZeneca PLC said it will cut another 7,300 jobs as it warned Thursday of a tough year ahead, due to government spending cuts on healthcare and stiff competition, even as it reported a 24 percent increase in 2011 profits.
- Novo Nordisk Q4 profits jump, outlook raised
(AP)
AP - Danish pharmaceutical company Novo Nordisk A/S reported Thursday that its fourth-quarter profits soared 19 percent on the back of strong sales of its key diabetes drugs Victoza, NovoRapid and Levemir.
- Jailed con artist describes role in Google case
(AP)
AP - When federal investigators decided to look into whether Google Inc. was letting rogue pharmacies from overseas target American consumers with advertising, they turned to a convicted con artist with experience pushing pills on the Internet.
- Overview of 4Q sales trends for Pfizer medicines
(AP)
AP - Here are sales figures for the fourth quarter for top-selling Pfizer prescription drugs:
- Lilly 4Q profit falls 27 pct, hurt by patent loss
(AP)
AP - Eli Lilly and Co.'s net income tumbled 27 percent in the last quarter of 2011 as the drugmaker faced another revenue-sapping patent expiration for a key product.
- Summary Box: Eli Lilly 4Q profit falls 27 percent
(AP)
AP - A BIG DROP: Drugmaker Eli Lilly and Co. said Tuesday its fourth-quarter net income fell 27 percent. Lilly earned $858.2 million, or 77 cents per share, compared to $1.17 billion, or $1.05 per share, in the 2010 quarter. Revenue fell 2 percent to $6.05 billion.
- Generics take toll on Pfizer, Lilly profits
(Reuters)
Reuters - Competition from low-cost generic drugs squeezed quarterly profits at Pfizer Inc and Eli Lilly & Co but the drugmakers were able to somewhat weather those declines with help from other medicines.
- Eli Lilly profit drops sharply on Zyprexa generics
(Reuters)
Reuters - Eli Lilly & Co's quarterly profit dropped 27 percent after its top-selling Zyprexa schizophrenia treatment lost U.S. patent protection and saw competition from generic rivals.
- Gates Foundation, drugmakers push on tropical ills
(AP)
AP - Thirteen major pharmaceutical companies, government groups and health charities will work together in a push to eliminate or control by 2020 10 tropical diseases that affect more than a billion people in poor countries.
- FDA approves Roche skin cancer drug Erivedge
(AP)
AP - Federal regulators on Monday approved a pill that treats the most common type of skin cancer, basal cell carcinoma.
- Amylin's long-delayed diabetes drug gets FDA nod
(AP)
AP - Amylin Pharmaceuticals won approval Friday for its long-delayed diabetes drug Bydureon, a next-generation treatment that requires fewer injections than the company's 7-year old diabetes medicine, Byetta.
- FDA clears Pfizer drug for advanced kidney cancer
(AP)
AP - Patients with hard-to-treat kidney cancer that has spread to other parts of the body gained a new drug option Friday, after federal regulators approved a twice-a-day pill from Pfizer for the disease.
- Pfizer sued in Puerto Rico over retirement plans
(AP)
AP - Employees of Pfizer Inc. have filed suit against the company, alleging the world's largest drug maker failed to properly manage its retirement plans and caused losses totaling hundreds of millions over the past decade in one of the hubs of the pharmaceutical industry.